Cognition Therapeutics Inc (NASDAQ: CGTX) is -76.22% lower on its value in year-to-date trading and has touched a low of $0.34 and a high of $2.95 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CGTX stock was last observed hovering at around $0.44 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.44, the stock is -13.65% and -10.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing -0.90% at the moment leaves the stock -68.61% off its SMA200. CGTX registered -57.69% loss for a year compared to 6-month loss of -83.21%. The firm has a 50-day simple moving average (SMA 50) of $0.49654 and a 200-day simple moving average (SMA200) of $1.410705.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -8.81% gain in the last 1 month and extending the period to 3 months gives it a -41.99%, and is -18.08% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.46% over the week and 11.98% over the month.
Cognition Therapeutics Inc (CGTX) has around 28 employees, a market worth around $18.28M and $0.00M in sales. Distance from 52-week low is 29.41% and -85.08% from its 52-week high. The company has generated returns on investments over the last 12 months (-230.40%).
The EPS is expected to grow by 0.74% this year
41.0 institutions hold shares in Cognition Therapeutics Inc (CGTX), with institutional investors hold 24.67% of the company’s shares. The shares outstanding are 40.13M, and float is at 33.80M with Short Float at 2.41%. Institutions hold 24.53% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.15 million shares valued at $1.9 million. The investor’s holdings represent 3.4016 of the CGTX Shares outstanding. As of 2024-06-30, the second largest holder is AWM INVESTMENT COMPANY, INC. with 0.65 million shares valued at $1.08 million to account for 1.9268 of the shares outstanding. The other top investors are ALYESKA INVESTMENT GROUP, L.P. which holds 0.5 million shares representing 1.4821 and valued at over $0.83 million, while TIMELO INVESTMENT MANAGEMENT INC. holds 1.0713 of the shares totaling 0.36 million with a market value of $0.6 million.
Cognition Therapeutics Inc (CGTX) Insider Activity
The most recent transaction is an insider purchase by Ricciardi Lisa, the company’s CEO & President. SEC filings show that Ricciardi Lisa bought 5,700 shares of the company’s common stock on Mar 14 ’24 at a price of $1.75 per share for a total of $9975.0. Following the purchase, the insider now owns 0.29 million shares.
